[HTML][HTML] Anti-angiogenic agents in ovarian cancer: past, present, and future
LE Minion, RL Coleman - Annals of oncology, 2016 - Elsevier
Angiogenesis plays a pivotal role in normal ovarian physiology as well as in the progression
of ovarian cancer through ascites formation and metastatic spread. Bevacizumab (Avastin® …
of ovarian cancer through ascites formation and metastatic spread. Bevacizumab (Avastin® …
[HTML][HTML] Anti-angiogenic agents in ovarian cancer: past, present, and future
BJ Monk, LE Minion, RL Coleman - Annals of Oncology, 2016 - ncbi.nlm.nih.gov
Angiogenesis plays a pivotal role in normal ovarian physiology as well as in the progression
of ovarian cancer through ascites formation and metastatic spread. Bevacizumab (Avastin® …
of ovarian cancer through ascites formation and metastatic spread. Bevacizumab (Avastin® …
Anti-angiogenic agents in ovarian cancer: Past, present, and future
BJ Monk, LE Minion… - Annals of …, 2016 - mdanderson.elsevierpure.com
Angiogenesis plays a pivotal role in normal ovarian physiology as well as in the progression
of ovarian cancer through ascitesformation and metastatic spread. Bevacizumab (Avastin® …
of ovarian cancer through ascitesformation and metastatic spread. Bevacizumab (Avastin® …
[引用][C] Anti-angiogenic agents in ovarian cancer: past, present, and future
BJ Monk, LE Minion, RL Coleman - Annals of Oncology, 2016 - cir.nii.ac.jp
Anti-angiogenic agents in ovarian cancer: past, present, and future | CiNii Research CiNii 国立
情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす …
情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす …
Anti-angiogenic agents in ovarian cancer: past, present, and future
BJ Monk, LE Minion, RL Coleman - Annals of Oncology, 2016 - annalsofoncology.org
Angiogenesis plays a pivotal role in normal ovarian physiology as well as in the progression
of ovarian cancer through ascites formation and metastatic spread. Bevacizumab (Avastin® …
of ovarian cancer through ascites formation and metastatic spread. Bevacizumab (Avastin® …
[引用][C] Anti-Angiogenic Agents in Ovarian Cancer: Past, Present, and Future
BJ Monk, L Minion, RL Coleman - Annals of Oncology, 2016 - researchworks.creighton.edu
Anti-angiogenic agents in ovarian cancer: past, present, and future.
BJ Monk, LE Minion, RL Coleman - Annals of Oncology: Official …, 2016 - europepmc.org
Angiogenesis plays a pivotal role in normal ovarian physiology as well as in the progression
of ovarian cancer through ascites formation and metastatic spread. Bevacizumab (Avastin® …
of ovarian cancer through ascites formation and metastatic spread. Bevacizumab (Avastin® …
Anti-angiogenic agents in ovarian cancer: past, present, and future
BJ Monk, LE Minion… - Annals of oncology …, 2016 - pubmed.ncbi.nlm.nih.gov
Angiogenesis plays a pivotal role in normal ovarian physiology as well as in the progression
of ovarian cancer through ascites formation and metastatic spread. Bevacizumab (Avastin …
of ovarian cancer through ascites formation and metastatic spread. Bevacizumab (Avastin …